Anti-eIF4G1 antibody
4
(3 Reviews)
|
(23 Publications)
Rabbit Polyclonal eIF4G1 antibody. Suitable for IHC-P, IP, ICC/IF, WB and reacts with Human, Rat, African green monkey samples. Cited in 23 publications. Immunogen corresponding to Synthetic Peptide within Human EIF4G1 aa 550-650.
View Alternative Names
EIF4F, EIF4G, EIF4GI, EIF4G1, Eukaryotic translation initiation factor 4 gamma 1, eIF-4-gamma 1, eIF-4G 1, eIF-4G1, p220
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-eIF4G1 antibody (AB2609)
ab2609 (4µg/ml) staining eIF4G1 in human colon using an automated system (DAKO Autostainer Plus). Using this protocol there is strong staining of the cytoplasm of the intestinal cells.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-eIF4G1 antibody (AB2609)
ICC/IF image of ab2609 stained MCF7 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab2609, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- IP
Supplier Data
Immunoprecipitation - Anti-eIF4G1 antibody (AB2609)
Lane 1 : immunoprecipitated by ab2609 at 6 μg per reaction; Lane 2 : Immunoprecipitated by control IgG at 6 μg per reaction.
All lanes:
Immunoprecipitation - Anti-eIF4G1 antibody (ab2609) at 1 µg/mL
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate
Lane 2:
HeLa whole cell lysate
Predicted band size: 175 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-eIF4G1 antibody (AB2609)
Lysates prepared using NETN lysis buffer.
All lanes:
Western blot - Anti-eIF4G1 antibody (ab2609) at 0.1 µg/mL
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 50 µg
Lane 2:
HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 50 µg
Predicted band size: 175 kDa
false
Exposure time: 3min
- WB
Unknown
Western blot - Anti-eIF4G1 antibody (AB2609)
50μg (lane 1) and 150μg (lane 2) rat liver lysate, separated on 7.5% acrylamide SDS-PAGE gel. Detected using ab2609 at 1 : 1000 (A), 1 : 5000 (B) and 1 : 10000 (C) dilution by ECL.
50µg (lane 1) and 150µg (lane 2) rat liver lysate, separated on 7.5% acrylamide SDS-PAGE gel. Detected using ab2609 at 1 : 1000 (A), 1 : 5000 (B) and 1 : 10000 (C) dilution by ECL.
All lanes:
Western blot - Anti-eIF4G1 antibody (ab2609)
Predicted band size: 175 kDa
false
Reactivity data
Properties and storage information
Form
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF4G1 functions as part of the eIF4F complex facilitating the initiation of cap-dependent translation. This process directly affects the synthesis of proteins that are important for growth and cell cycle progression. As an important component in translation eIF4G1 coordinates interactions between mRNA and ribosomes ensuring efficient translation initiation and progression.
Pathways
EIF4G1 is significant in the mTOR and MAPK signaling pathways. These pathways regulate various cellular processes such as cell growth proliferation and survival. eIF4G1 interacts with related proteins like eIF4E which binds the 5' cap of mRNA and eIF4A an RNA helicase both critical in these signaling cascades.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (23)
Recent publications for all applications. Explore the full list and refine your search
Clinical and translational medicine 15:e70270 PubMed40088428
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2309234 PubMed38380498
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 51:8820-8835 PubMed37449412
2023
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 7: PubMed36125898
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 47: PubMed33693953
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:2795-2805 PubMed33539648
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 20:449 PubMed32943997
2020
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 8: PubMed27447663
2016
Applications
Unspecified application
Species
Unspecified reactive species
eLife 4: PubMed26678009
2015
Applications
WB
Species
Unspecified reactive species
Cancer discovery 5:255-63 PubMed25564516
2015
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com